Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03323801 · ClinicalTrials.gov registry record · Phase 2
RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT03323801 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 10 participants.
The verdict
NCT03323801, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
Men with infertility and normal hormone levels have few options for fertility treatment. Previous research suggests that men with infertility may have low levels of the active form of Vitamin A, called retinoic acid, in their testes. In a pilot study of 20 men with low numbers of sperm (\<10 million motile sperm), roughly half the men showed improvement in sperm production. Thus, we want to see if retinoic acid administration to men with azoospermia (no sperm present) can initiate sperm production.
Interventions
- DRUG 13-cis retinoic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-07-25 |
| Est. Completion | 2019-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03323801
The ClinicalTrials.gov registry entry for NCT03323801 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 13-cis retinoic acid is the first listed.
NCT03323801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03323801 about?
NCT03323801 is a clinical study titled "RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia". Men with infertility and normal hormone levels have few options for fertility treatment. Previous research suggests that men with infertility may have low levels of the active form of Vitamin A, called retinoic acid, in their testes. In a pilot study of 20 men with low numbers of sperm (\<10 million...
What is the current status of trial NCT03323801?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2017-07-25. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03323801?
The interventions under investigation include: 13-cis retinoic acid (DRUG).
Who is sponsoring clinical trial NCT03323801?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.